| EVIDENT Announces Alliance to Automate Digital Pathology Workflows We have announced an alliance with Corista, Sakura Finetek USA, and Visiopharm to deliver an automated, end-to-end workflow solution for pathology. Get all the details in the press release. |
| 胃がんAI病理診断支援ソフトウェア、連続症例における評価でAUC0.96を達成 独立行政法人国立病院機構呉医療センター・中国がんセンター（院長：下瀨 省二）を含む国内医療機関7施設との共同研究で開発した胃がんAI病理診断支援ソフトウェアが、学習データに使用していない施設での連続症例における評価でAUC0.96を達成しました。 |
| EVIDENT Corporation, 새로운 CEO 및 COO 임명 |
| EVIDENT, 2022년 올해의 글로벌 이미지 수상자 발표 수상작이 선정되었습니다! 세계 최고의 과학 이미징을 대표하는 연례 공모전인 2022년 올해의 과학 광학 현미경 글로벌 이미지상의 수상자를 확인해 보세요. 보도 자료를 통해 자세한 내용을 알아보세요. |
| EVIDENT Discovery Center Inaugurated at the University of Montreal |
| 현미경 품질의 이미지와 빠른 슬라이드 스캔 기능이 조합된 SLIDEVIEW™ DX로 효율적인 디지털 병리학 실현 |
| ホールスライドイメージングシステム「SLIDEVIEW VS-M1J」を発売 株式会社エビデント（本社：東京都新宿区、社長：エリック アンダーソン）は、病理検査向けにスライドガラス標本を画像データ化するホールスライドイメージングシステム「SLIDEVIEW VS-M1J（スライドビュー ヴイエス-エムワンジェイ）」を2023年6月1日より国内で発売します。 |
| Evident Announces Interim CEO Evident Corporation (“Evident”) today announced the appointment of Eric Anderson, a current member of the Office of the CEO, as Interim CEO. He takes on the responsibilities of Yoshitake Saito, who assumes the role of Chairman effective immediately. |
| SLIDEVIEW™ VS200, 흐림 없는 고대비 영상을 위한 광학적 단층 촬영 장치 추가 |
| Evident Acquired by Bain Capital: Partnership to Accelerate Future Growth and Innovation |
| Notice Concerning Postponement of Closing of Transfer of Shares of Evident Corporation |
| Postponement of the Transfer of all Shares of EVIDENT Corporation from Olympus to Bain Capital |
| 2023 EVIDENT Organoid Conference to Share the Latest Organoid Innovations |
Not Available in Your Country
Sorry, this page is not
available in your country.
You are being redirected to our local site.